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Maternal smoking during pregnancy contributes to long-term health problems in offspring, 33 
especially respiratory disorders which can manifest in either childhood or adulthood. Receptors for 34 
advanced glycation end-products (RAGE) are multi-ligand receptors abundantly localized in the 35 
lung, capable of responding to by-products of reactive oxygen species and pro-inflammatory 36 
responses. RAGE signalling is a key regulator of inflammation in cigarette smoking-related 37 
pulmonary diseases.  However, the impact of maternal cigarette smoke exposure on lung RAGE 38 
signalling in the offspring is unclear. This study aims to investigate the effect of maternal cigarette 39 
smoke exposure (SE), as well as MitoQ (mitochondria-targeted antioxidant) treatment during 40 
pregnancy on RAGE-mediated signalling pathway in the lung of male offspring.  41 
Female Balb/c mice (8 wk) were divided into a sham group (exposed to air), an SE group (exposed 42 
to cigarette smoke) and an SE+MQ group (exposed to cigarette smoke with MitoQ supplement 43 
from mating). The lungs from male offspring were collected at 13 weeks.  44 
Results: RAGE and its downstream signaling including NF-κB and MAPK family consisting of 45 
ERK1, ERK2, JNK, and phosphorylated-JNK in the lung were significantly increased in the SE 46 
offspring. Mitochondrial antioxidant manganese superoxide dismutase (MnSOD) was reduced, 47 
while IL-1β and oxidative stress response nuclear factor (erythroid-derived 2)-like 2 (Nrf-2) was 48 
significantly increased in the SE offspring. Maternal MitoQ treatment normalised RAGE, IL-1β and 49 
Nrf-2 levels in the SE+MQ offspring.  50 
Maternal SE increased RAGE and its signalling elements associated with increased oxidative stress 51 
and inflammatory cytokines in offspring’s lungs; whereas maternal MitoQ treatment can partially 52 






Maternal smoking during pregnancy contributes to various long-term health problems in offspring, 56 
especially respiratory disorders (21, 37). Several human studies have indicated that maternal 57 
smoking is associated with lung under-development, airflow limitations, increase in the risk of 58 
respiratory infections and development of airway hypersensitivity and asthma (7, 62, 64). Several 59 
mechanisms have been proposed, including a reduction in the development or physical size of the 60 
lung including reduced elastic tissue and the number of alveolar attachments to the airway, an 61 
increase in oxidative stress, and alteration to the inflammatory response and immune system (14, 62 
17, 41, 42).  63 
 64 
Receptors for advanced glycation end-products (RAGE) are multi-ligand receptors abundantly 65 
localized in the lung (16). Recent studies have implied a role of RAGE in cigarette-smoking-related 66 
diseases, where RAGE signaling is a key regulator of inflammatory response in pulmonary diseases 67 
(13, 48). Cigarette smoke induces the formation of advanced glycation end-products (AGEs), 68 
resulting in the development of diseases through the AGEs-RAGE axis (8, 44). Indeed, it has been 69 
reported that serum levels of AGEs are elevated in smokers including both current and past smokers 70 
(40), and  RAGE levels are elevated in pulmonary tissue from mice exposed to cigarette smoke (20, 71 
65). AGEs can interact with RAGE leading to pro-inflammatory responses via several downstream 72 
kinases, such as the Mitogen-activated protein kinase (MAPK) family consisting of extracellular 73 
signal-regulated kinase-1/2 (ERK1/2), c-JUN N-terminal kinase (JNK) and p38MAPK. The 74 
transcription factor nuclear factor-κ -light-chain-enhancer of activated B cells (NF-κB) can also be 75 
activated, which results in the expression of a variety of pro-inflammatory mediators and cytokines, 76 
including IL-1, IL-6 and TNF-α (30, 32, 45). Thus, the activation of RAGE-mediated signalling 77 
pathways is likely to play a key role to mediate inflammatory response in many pulmonary 78 
disorders (47). In a previous study, short-term maternal cigarette smoke exposure during embryo 79 
days 14.5-18.5 was shown to increased RAGE level in the fetal lung tissue at embryo day 18.5 80 
(63). However, whether such changes are still present at adulthood is unknown.  81 
 82 
Pathological responses induced by the AGEs-RAGE axis are mediated by the generation of 83 
intracellular reactive oxygen species (ROS), the ensuing oxidative stress (15), and the activation of 84 
ROS induced cytokine production and inflammation.  Mitochondria are the major cellular source of 85 




oxidative stress can induce the secretion of inflammatory cytokines and the expression of adhesion 87 
molecules and inflammatory mediators in the lung (3, 24, 27). It has also been shown that maternal 88 
smoking can significantly increase oxidative stress in the offspring, including the lung tissue (4). 89 
Therefore, reducing oxidative stress may reduce pulmonary inflammatory responses in the lungs of 90 
offspring from smoking parents. 91 
 92 
Coenzyme Q10 (CoQ10) is a mitochondrial endogenous antioxidant. It has been shown that CoQ10 93 
dietary supplementation (1%) in mice with diet-induced obesity can lower liver markers of 94 
inflammation and oxidative stress (55). Plasma CoQ10 levels are reduced in smokers (1). However, 95 
mitochondrial intake of commercial CoQ10 is very low via oral supplementation, thus a 96 
superphysiological dose was used in the abovementioned study. Mitoquinone mesylate, also known 97 
as MitoQ, is a mitochondria-targeted antioxidant. It consists of a ubiquinone moiety, the same 98 
structure to the ubiquinone found in CoQ10 that is linked to a triphenylphosphonium moiety by a 99 
ten-carbon alkyl chain, which allows its rapid uptake and accumulation in the mitochondria to 100 
restore the antioxidant efficacy of the mitochondrial respiratory complex (26). As such, it has been 101 
reported that MitoQ has a protective role against oxidative damage-related pathologies in metabolic 102 
disease (36) and neurodegenerative diseases (34). Amniotic fluid CoQ10 levels are significantly 103 
lower among women delivering preterm babies, a risk which is increased by maternal smoking (29, 104 
60). Therefore, MitoQ might be a suitable intervention option since it is already marked for human 105 
consumption.  106 
 107 
Thus, the main aim of this study was to investigate the long-term impact of maternal cigarette 108 
smoke exposure (SE) on lung RAGE signalling elements in adult offspring. In addition, whether 109 
MitoQ supplementation during gestation can mitigate the adverse impact of maternal SE was also 110 
investigated. 111 
 112 
MATERIALS AND METHODS 113 
Animal experiments 114 
The animal experiments were approved by the Animal Care and Ethics Committee at the University 115 
of Technology Sydney (ACEC#2014-638 and #2016-419).  All protocols were performed 116 
according to the Australian National Health & Medical Research Council Guide for the Care and 117 
Use of Laboratory Animals. Female Balb/c mice (8 weeks) were housed at 20 ± 2 °C and 118 




water. After the acclimatisation period, mice were divided into the following three groups: sham 120 
(exposed to air), SE (exposed to 2 cigarettes twice daily, 6 weeks before mating and throughout 121 
gestation and lactation, as previously described (2)), and SEMQ (SE mothers supplied with MitoQ 122 
(1.5 g/L in drinking water) during gestation and lactation).  This dose was chosen as it has 123 
previously shown to be effective, safe and maintain steady-state tissue concentrations of 1-100 pmol 124 
MitoQ/per g of tissue(36, 49) (depending upon the organ analysed; MitoQ accumulates in liver and 125 
heart, but is effective in the lung with this dosing regimen (33)). Male breeders and suckling pups 126 
stayed in the home cage when mothers were exposed to sham or cigarette smoke. Pups were 127 
weaned at postnatal day 20 and maintained without additional intervention. Male offspring were 128 
euthanized (4% isoflurane, 1% O2, Veterinary companies of Australia, Kings Park, NSW) at 13 129 
weeks (mature age) and the lung tissues were collected and stored at -80°C for later analysis.   130 
 131 
Western blotting  132 
Lungs tissues were homogenized in lysis buffer with phosphatase inhibitors (Thermo Fisher 133 
Scientific, CA, USA). Protein concentrations were measured using DC Protein assay (Bio-rad, 134 
Hercules, CA, USA). Equal amount of proteins (20 μg) were separated on NuPage® Novex® 4–135 
12% Bis-Tris gels (Thermo Fisher Scientific, CA, USA) and transferred to PVDF membranes. The 136 
membranes were blocked with TBS-0.05% Tween 20 (TBS-T) containing 5% BSA or skim milk 137 
for 1 h, before incubation with primary antibodies against phospho-Erk1/2 (1:1000, Cell Signaling 138 
Technology Inc), Erk1/2 (1:1000, Cell Signaling Technology Inc, MA, USA), phospho-JNK 139 
(1:1000, Cell Signaling Technology Inc, MA, USA), JNK (1:500, Cell Signaling Technology Inc, 140 
MA, USA), phospho-p38 MAPK (1:1000, Cell Signaling Technology Inc, MA, USA), p38 MAPK 141 
(1:1000, Cell Signaling Technology Inc, MA, USA), NF-κB and phospho-NF-κB (1:1000, Cell 142 
Signaling Technology Inc, MA, USA), IL-6 (1:1000, Cell Signaling Technology Inc, MA, USA), 143 
IL-1β (1:1000, Cell Signaling Technology Inc, MA, USA), RAGE (1:1000, GeneTex Inc, CA, 144 
USA), TNF-α (1:1000, Gene Tex Inc, CA, USA), antioxidant response element nuclear factor 145 
(erythroid-derived 2)-like 2 (Nrf-2, 1:500, Aviva System Biology, CA, USA), endogenous 146 
antioxidant Manganese superoxide dismutase (MnSOD, 1:1000, Santa Cruz Biotechnology, Texas, 147 
USA), transforming growth factor-β1 (TGF-β1, 1:500, R&D Systems, MN, USA), and collagen 1A  148 
(1:1000, Santa Cruz Biotechnology Inc, Texas, USA) overnight at 4°C, which was followed by 149 
secondary antibodies (peroxidase-conjugated goat anti-mouse or anti-rabbit IgG, 1:2000, Santa 150 




Chemiluminescent substrate (Thermo Fisher Scientific, CA, USA) and the membranes were then 152 
visualized by an Amersham Imager 600 (GE Healthcare, NSW, Australia). Protein band density 153 
was determined using ImageJ software (National Institute of Health, Maryland, USA) for 154 
densitometry, and β-actin (1:5000, Santa Cruz Biotechnology, Texas, USA) was used as the 155 
housekeeping protein. 156 
 157 
Quantitative real-time PCR  158 
Total mRNA was isolated from lung tissues using TRIzol Reagent (Life Technologies, CA, USA). 159 
First strand cDNA was generated using M-MLV Reverse Transcriptase, RNase H, Point Mutant Kit 160 
(Promega, Madison, WI, USA). Real-time PCR was performed using manufacturer pre-optimized 161 
and validated TaqMan® primers and probes (Thermo Fisher Scientific, CA, USA). Only RAGE 162 
probe sequence is provided by the manufacturer (CCCAGGCGTGAGGAGAGGAAGGCC, NCBI 163 
gene references: NM_001271422.1, NM_001271424.1, NM_007425.3; ID: Mm01134790_g1). 164 
RAGE probes were labelled with FAM® dye and those for housekeeping 18s rRNA was labelled 165 
with VIC® dye. Gene expression was standardized to 18s RNA. The average expression of the 166 
control group was assigned as the calibrator against which all other samples were expressed as fold 167 
difference. 168 
 169 
Statistical analysis 170 
The results are presented as the mean ± S.E.M. The data were analysed by one-way ANOVA 171 
followed by post hoc Bonferroni test (Prism 7, Graphpad CA, USA). The differences were 172 
considered statistically significant at P < 0.05. 173 
 174 
RESULTS 175 
Effect on the body weight of offspring  176 
At postnatal day 1, as expected male offspring from the SE mothers (1.30 ± 0.07g, n=11) were 177 
significantly smaller than those from the SHAM mothers (1.49 ± 0.03g, P<0.01, n=17). Smaller 178 
body weight was maintained until 13 weeks of age (SE 24.3 ± 0.2g n=21, SHAM 25.3 ± 0.3g n=20, 179 
P<0.01), which was consistent with our previous study using the same model (25).  180 
 181 
MitoQ supplementation during gestation and lactation significantly reversed in the impact of 182 




n=7). In adulthood, the body weight of SEMQ offspring was also normalised to the Sham level 184 
(25.2 ± 0.2g, P=0.01 vs SE, n=12).   185 
 186 
Effect on lung RAGE and MAPK signalling elements in offspring 187 
Maternal smoking increased the amount of RAGE protein in adult offspring’s lungs (P<0.05 vs 188 
SHAM; Fig. 1a) which was reduced by MitoQ. At the mRNA level, RAGE was only slightly 189 
reduced in the SE offspring at 13 weeks, but increased by MitoQ (Fig.1b). RAGE downstream 190 
signalling molecules including total Erk1, Erk2, JNK, and p-JNK protein levels were increased in 191 
SE offspring (P<0.05 vs SHAM; Fig.2 a-c); however, p-Erk1 and p-Erk2 levels were not different 192 
between SHAM and SE group. There was no change in total or phosphorylated p38MAPK between 193 
the SHAM and SE groups (Fig. 2d). Maternal MitoQ supplementation during gestation marginally 194 
reduced total ERK1 and ERK2, as well as p-ERK1 and p-ERK2 levels, although without statistical 195 
significance (Fig 2). 196 
 197 
Effects on lung antioxidant enzyme in offspring  198 
Manganese superoxide dismutase (MnSOD) is the primary endogenous mitochondrial antioxidant 199 
that plays a key role in protecting cells against oxidative stress. As shown in Figure 3, 200 
mitochondrial levels of MnSOD were significantly reduced in the SE offspring (P < 0.05), which 201 
was only slightly enhanced by maternal MitoQ treatment. Furthermore, Nrf-2, a transcription factor 202 
which is high sensitivity to oxidative stress, was significantly increased in the SE offspring (P < 203 
0.05 vs SHAM; Fig. 4a), which was normalised by maternal MitoQ supplemenation (P<0.05 vs 204 
SE; Fig. 4b). 205 
 206 
Effects on lung pro-inflammatory mediators in offspring 207 
RAGE-induced release of pro-inflammatory cytokines is mainly via the activation of NF-κB, a 208 
redox-sensitive transcription factor that regulates the transcription of several pro-inflammatory 209 
cytokines. There was a nonsignificant trend towards increasing levels of phosphorylated NF-κB in 210 
SE offspring, and the the total NF-κB level was significantly increased in SE offspring compared to 211 
SHAM offspring (P < 0.05; Fig.4a,b). As a result, the ratio of  phosphorylated NF-κB / total  NF-κB 212 
was unchanged. Similarly, IL-1β protein level was more than doubled in SE offspring (P < 0.05; 213 




However, IL-6 levels were similar between the SHAM and SE group (Fig. 4c). Maternal MitoQ 215 
supplementation normalised phosphorylated and total NF-κB and IL-1β levels in SEMQ offspring 216 
(Fig 4a,b), without any effect on IL-6 and TNF-α (Fig 4c,d).   217 
 218 
Effect on lung fibrotic markers in offspring 219 
A prolonged increase in TGF-β1 activity can lead to persistent lung fibrosis resulting in excessive 220 
production of collagen-1A (11). Here, neither TGF-β1 nor collagen-1A proteins levels were 221 
changed in 13 weeks old SE offspring (Fig.5). Maternal MitoQ treatment also showed no impact on 222 
these two proteins (Fig.5). 223 
 224 
DISCUSSION 225 
Maternal smoking during pregnancy has been shown to adversely affect fetal lung development and 226 
has also been linked to an increased risk of long-term respiratory disorders (21, 37). In this study, 227 
we found that SE offspring had reduced body weight at birth which was maintained until adulthood. 228 
The protein levels of RAGE and its downstream signalling, including NF-κB and MAPK family 229 
consisting of ERK1, ERK2, JNK, and p-JNK, were significantly increased in the lung of SE 230 
offspring, with increased inflammatory cytokine IL-1β level. Mitochondrial antioxidant MnSOD 231 
levels were reduced, and the oxidative stress response Nrf-2 was significantly increased in the SE 232 
offspring. Maternal MitoQ treatment reversed the impact of maternal SE on birth weight and 233 
normalised RAGE, NF-κB, IL-1β and Nrf-2 levels in offspring. 234 
 235 
RAGE plays an important role in cigarette-smoking-related diseases as a key regulator in 236 
maintaining and promoting inflammatory responses (13, 48, 57). It has been shown that the 237 
expression of RAGE is increased in pulmonary epithelial cells after exposure to cigarette smoke 238 
extract (46), whereas increased inflammatory cytokines have been found in the lung lavage fluid of 239 
smokers and mice exposed to cigarette smoke (25, 28). To our knowledge, this is the first study to 240 
demonstrate that continuous maternal SE from pre-gestation to lactation leads to increased RAGE 241 
expression in the offspring’s lung at adulthood, with increased downstream signalling elements and 242 
inflammatory cytokines. The study by Winden et al. only showed RAGE augmentation in the fetal 243 
lung following 4 days maternal SE during the pseudoglandular period of lung development (63). 244 
This suggests that the changes in RAGE and signaling elements by maternal SE can begin in the 245 
intrauterine period, and last long into adulthood. In our study, RAGE mRNA expression was 246 




feedback loop. This suggests that the level of RAGE may be regulated at a transcriptional level. 248 
Additional studies will be required to determine the exact mechanism, such as the involvement of 249 
transcriptional regulator non-coding RNAs.  250 
 251 
The activation of RAGE signaling pathways can influence alveolar remodeling characteristics of 252 
pulmonary disease (50). Several studies have indicated that cigarette smoke induces the expression 253 
of RAGE and promotes the phosphorylation of ERK1/2, p38 and JNK in primary human gingival 254 
epithelial cells and in the lungs of rats exposed to cigarette smoke (52, 65, 66). Therefore, here we 255 
investigated the signal transduction pathways and fibrotic markers in lung tissue. In the present 256 
study, we demonstrated that maternal SE can increase the expression of RAGE-dependent 257 
signalling protein kinases including Erk1, Erk2, and JNK. However, the phosphorylation of these 258 
molecules was not significantly increased by maternal SE. Therefore, the impact of maternal SE on 259 
the health outcome of the offspring’s lung may prime the lung to be hyperresponsive to certain 260 
stimuli, but the pathways themselves are not intrinsically activated.  This is consistent with studies 261 
in humans, where smoking during pregnancy is a risk factor for the development of lung diseases 262 
such as asthma and COPD, but in both of these diseases other environmental stimuli are mostly 263 
needed to develop the disease in children.  264 
 265 
The two fibrotic markers measured in this study were not affected by maternal SE. This is 266 
consistent with the changes in fibrotic markers in the kidney in our previous study using the same 267 
model of maternal SE (2). Increased collagen deposition has been found in foetal lung tissue of 268 
monkeys due to maternal nicotine administration (51). Such differences may be due to the dose of 269 
nicotine administered. In our study the nicotine dose was low (equivalent to a human smoking 1-2 270 
cigarettes/day).  The other significant difference is that cigarette smoke is a complex mixture of 271 
chemicals which may inhibit or enhance the effects of nicotine.    272 
 273 
Cigarette smoke contains free radicals, and itself can stimulate the production of ROS in lung 274 
tissues, leading to oxidative damage in both pregnant women and newborns (12, 18). MnSOD is an 275 
enzyme present in mitochondria that is one of the first-line enzymes to detoxify the superoxide 276 
radicals generated during ATP synthesis (6). Here we showed that the level of mitochondrial 277 
MnSOD was reduced in the offspring’s lung in response to maternal SE. This is consistent with our 278 
findings in the brain and kidneys of SE offspring in adulthood in our previous studies (10, 56).  279 
RAGE activation by multiple ligands such as ceramides, cigarette smoke (39), or intracellular 280 




production (22).   Given this it is likely that reduced MnSOD in the current experiments is the result 282 
of mitochondrial damage. 283 
 284 
Additionally, Nrf2 is a transcription factor that responds to oxidative stress and contributes to the 285 
induction of several protective enzymes to scavenge excess free radicals during oxidative stress. 286 
Nrf2 was found be increased in moderate smokers in response to increased oxidative stress induced 287 
by cigarette smoke (19). Here, we found that Nrf2 was significantly increased in the SE offspring at 288 
adulthood, in line with their increased oxidative stress markers. Taken together, maternal cigarette 289 
smoking during pregnancy may cause long lasting oxidative stress in offspring’s lungs, possibly due 290 
to the reduction of protective antioxidative enzymes.  291 
 292 
Prolonged oxidative stress can activate the redox-sensitive transcription factor NF- B (61), which, 293 
in turn, results in the transcription of a variety of mRNA encoding pro-inflammatory cytokines (43). 294 
In the present study, the level of NF-κB in offspring from SE mothers was higher than those from 295 
the SHAM mothers. This is in keeping with increased protein levels of the pro-inflammatory 296 
cytokines interleukin-1β and TNF-α, both of which are the downstream targets of NF-κB. It has 297 
been reported that chronic production of IL-1β can lead to pulmonary inflammation, emphysema, 298 
airway remodelling, and bronchial hyper-reactivity which are the main features of asthma and 299 
COPD (23, 31, 35). Therefore, maternal smoking during pregnancy may increase the risk of chronic 300 
inflammatory conditions in offspring’s lungs, making them more susceptible to certain pulmonary 301 
disorders such as COPD in adulthood, which requires further investigation.  302 
 303 
Mitochondrial oxidative damage occurs in many disease states. Therefore, strategies to prevent 304 
oxidative-stress-induced damage may provide new therapeutic options for a range of human 305 
disorders, including lung diseases (5). MitoQ is, to date, the best-characterised mitochondria-306 
targeted ubiquinone (53), which reduces the potent antioxidant mitoquinol in the mitochondria (26). 307 
MitoQ has been used in several organ systems, but as far as we know never before for pulmonary 308 
disorders (9, 36, 38, 54). In the present study, we determined the effects of maternal MitoQ 309 
supplementation during pregnancy on the health outcome of the lungs in offspring. Although 310 
maternal MitoQ treatment in SE mothers did not affect endogenous MnSOD level in the offspring, 311 
oxidative stress seems to be reduced, reflected by normalised Nrf-2 level. RAGE levels in the 312 
SEMQ offspring were also reduced. The activity of MAP kinase family members did not seem to be 313 




can further normalise pro-inflammatory cytokine levels (including IL-1β and TNF-α) in the 315 
offspring’s lung. Taken together, our findings suggest that the administration of the mitochondria-316 
targeted antioxidant MitoQ may be beneficial to lung health outcomes in offspring from SE 317 
mothers. 318 
 319 
In summary, maternal SE can enhance oxidative stress and the expression of RAGE, as well as 320 
promoting RAGE-mediated inflammatory responses in offspring’s lungs. Maternal MitoQ 321 
supplementation during pregnancy is beneficial in reducing inflammatory and oxidative stress 322 
responses caused by maternal SE. Future human translation may be plausible since MitoQ is 323 
already marketed as over-the-counter dietary supplement.  324 
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Figure legends: 524 
Figure 1. RAGE in the Lung. Protein expression of RAGE (a) and mRNA expression of RAGE (b) 525 
in the lung from male offspring at 13 weeks. Results are expressed as mean ± S.E.M of n=9 mice. 526 
Data were analysed by one-way ANOVA followed by post hoc Bonferroni test. * P < 0.05 vs Sham; 527 
# P < 0.05 vs SE. SE: smoke exposed; SEMQ: smoke exposed with dietary supplementation of 528 
MitoQ. 529 
 530 
Figure 2. Lung Erk1, Erk2, JNK and p38MAPK protein expression. Protein expression of 531 
phosphorylated and total Erk1 (a), Erk2 (b), JNK (c) and p38MAPK (d) in the lung from male 532 
offspring at 13 weeks. Results are expressed as mean ± S.E.M of n=9 mice. Data were analysed by 533 
one-way ANOVA followed by post hoc Bonferroni test. * P < 0.05 vs Sham. Erk: extracellular 534 
signal-regulated kinase; JNK: c-JUN N-terminal kinase; p38MAPK: p38 Mitogen-activated protein 535 
kinase; SE: smoke exposed; SEMQ: smoke exposed with dietary supplementation of MitoQ. 536 
 537 
Figure 3. Lung Oxidative stress markers. Mitochondrial MnSOD (a) and total tissue Nrf-2 (b) 538 
protein level in the lung from male offspring at 13 weeks. Results are expressed as mean ± S.E.M of 539 
n=8 mice. Data were analysed by one-way ANOVA followed by post hoc Bonferroni test. * P < 540 
0.05 vs Sham; # P < 0.05 vs SE. MnSOD: Manganese superoxide dismutase; Nrf-2: Nuclear factor 541 
erythroid 2-related factor 2; SE: smoke exposed; SEMQ: smoke exposed with dietary 542 
supplementation of MitoQ. 543 
 544 
Figure 4. Lung Inflammatory markers. NF-κB (a-c), Interleukin-1β (d), interleukin-6 (e) and TNF-α 545 
(f) protein levels in the lung from male offspring at 13 weeks. Results are expressed as mean ± 546 
S.E.M of n=9 mice. Data were analysed by one-way ANOVA followed by post hoc Bonferroni test. 547 
*P < 0.05 vs Sham. NF-κB: nuclear factor-κB; SE: smoke exposed; SEMQ: smoke exposed with 548 
dietary supplementation of MitoQ. 549 
 550 
Figure 5. Markers of Lung fibrosis. TGF-β1 (a) and Collagen-1A (b) protein levels in the lung from 551 
male offspring at 13 weeks). Results are expressed as mean ± S.E.M of n=9 mice. Data were 552 
analysed by one-way ANOVA. SE: smoke exposed; SEMQ: smoke exposed with dietary 553 
supplementation of MitoQ; TGF-β1: Transforming growth factor β1. 554 
 555 
 556 
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